USPTO serial 76215726
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICALS FOR THE TREATMENT OF ISCHEMIA-INDUCED DISORDERS | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2002 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 19, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 28, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 26, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2001 | DOCK | ASSIGNED TO EXAMINER | — |